Features of the hemostasis system in patients with non-alcoholic fatty liver disease

Background. Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. In recent years, disorders in the hemostasis system, their role in the progression of liver diseases and the development of cardiovascular complications in NAFLD have been actively studied. The purpose was to investigate the features of the hemostasis system in patients with non-alcoholic fatty liver disease. Materials and methods. We examined 36 individuals with NAFLD (20 women and 16 men) aged 29–73 years. All patients underwent an anthropometric, general clinical, biochemical study of blood serum with the determination of platelets, prothrombin time ratio, international normalized ratio, fibrinogen, ultrasound examination of the abdominal cavity organs with elastometry, followed by statistical data processing. Results. Among patients with NAFLD, class 2 obesity and overweight (30.6% each), class 1 obesity (27.8%) prevailed. At the same time, according to the controlled attenuation parameter, 38.9% of people had a severe degree of steatosis, 33.3%— moderate and 27.8%— mild. Regarding the indicators of hemostasis, a significant increase in the level of fibrinogen up to (4.9±0.5) g/l was detected in 44.4% of patients, its severity tended to grow with an increase in the degree of hepatic steatosis. Conclusions. In 44.4% of NAFLD patients, with an increase in the degree of hepatic steatosis, the tendency to hypercoagulability has grown with an increase in fibrinogen content by 1.6 times (p<0.001). Changes in the international normalized ratio, prothrombin time ratio and platelets were determined in isolated cases: more than 83.3% of patients with NAFLD didn’t have violations of these parameters.